You are here
CRYOLIFE, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
N/A
Amount: $0.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
N/A
Amount: $314,781.00N/A
SBIRPhase II2000Department of Health and Human Services National Institutes of Health -
ENGINEERED HEART VALVE--FLOW AND FIBROBLAST FUNCTION
Amount: $744,296.00N/A
SBIRPhase II1997Department of Health and Human Services -
CRYOPRESERVED ARTERIES AS ALLOGRAFT VASCULAR CONDUIT
Amount: $99,984.00N/A
SBIRPhase I1997Department of Health and Human Services -
ENGINEERED HEART VALVE--FLOW AND FIBROBLAST FUNCTION
Amount: $99,484.00N/A
SBIRPhase I1996Department of Health and Human Services -
Bioadhesive for Surgery and Wound Repair
Amount: $99,782.00We will develop a strong, safe, easy-to-use, biocompatible, and degradable bioadhesive for surgicalrequiring tissue sealing and closure. This bioadhesive will have the potential to streamline commonwe ...
SBIRPhase I1995Department of Health and Human Services -
Xenogeneic Arterial Bypass Graft
Amount: $73,360.00Although the autogenous saphenous vein is the vessel typically utilized in arterial bypass procedurarise in which it is not possible to use this vein, demanding an alternative method. The investigatof ...
SBIRPhase I1995Department of Health and Human Services -
Fascia Lata Xenograft for ACL Replacement
Amount: $91,680.00Autologous patellar tendon grafts are the current gold standard for replacement of irreparable anteligaments. Allogeneic tissue grafts are the only accepted alternative to autologous grafts and theysu ...
SBIRPhase I1995Department of Health and Human Services -
Xenograft Heart Valves--Biomechanics/Collagen Structure
Amount: $74,576.00Though allograft human aortic valves are preferred for transplantation by virtue of their lowthrombogenicity and immunogenicity, superior hemodynamic performance, and extended durability, onlyabout 2, ...
SBIRPhase I1994Department of Health and Human Services -
DEVELOPMENT OF A FIBRIN SEALANT DELIVERY METHOD
Amount: $500,000.00FIBRIN SEALANT HAS MANY APPLICATIONS IN SURGERY. MIXING AND DELIVERY OF THE MAJOR COMPONENTS, FIBRINOGEN AND THROMBIN, IS CURRENTLY ACHIEVED USING TWO SYRINGES OR SPRAY CONTAINERS DISPENSED ALTERNATEL ...
SBIRPhase II1993Department of Health and Human Services
